By Finance Pulse in Transformative —

Retail Investors Flood Novo Nordisk Despite Obesity Drug Setback

U.S. retail investors dramatically increase fund flows into Novo Nordisk, with a 32-fold surge following disappointing obesity drug data. Discover the market reaction.

A sleek, modern illustration of financial graphs and charts with a rising arrow, symbolizing investm
Retail Investors Flood Novo Nordisk Despite Obesity Drug Setback

U.S. retail investor fund flows into Novo Nordisk surged 32-fold after the company's obesity drug data disappointed.

Source